Prospective non-interventional post authorization safety study (PASS) of idelalisib in Germany

27/04/2015
22/02/2024
EU PAS number:
EUPAS9564
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

amd-4-prot-GS-DE-312-1750

English (1.62 MB - PDF) View document
Updated protocol

protocol-GS-DE-312-1750-FINAL-COMPLETE

First published: 22/02/2024
English (857.15 KB - PDF) View document
Study results
Study results

GS-DE-312-1750-csr-abstract_f-redact

English (189.67 KB - PDF) View document
Study report
Other information